Clinical Trial Update: Fruquintinib Combined With Trifluridine/Tipiracil Versus Bevacizumab Combined With Trifluridine/Tipiracil for Advanced Metastatic Colorectal Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update comparing Fruquintinib plus trifluridine/tipiracil versus Bevacizumab plus trifluridine/tipiracil in advanced/metastatic colorec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• Fruquintinib (fruquintinib)
• trifluridine/tipiracil (trifluridine/tipiracil)

Snippet

Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Conditions: Metastatic Colorectal Cancer (CRC), Colorectal Cancer | Phase 2 | Status: NOT_YET_RECRUITING